BIOPAMA launches Calls for Proposals for 2022 grants
We are pleased to announce the launch of the Calls for Proposals for the latest BIOPAMA Action Component grants.
The BIOPAMA Action Component is a 21-million-Euro grant-making facility managed by IUCN (International Union for Conservation of Nature) in the frame of the BIOPAMA (Biodiversity and Protected Areas Management) Programme. BIOPAMA is an initiative of the African, Caribbean and Pacific (ACP) Group of States financed by the European Union’s 11th European Development Fund.
Photo: Simone vom Feld / Pixabay
Protected and conserved areas and the landscapes within which they are located have a central role to play in preserving the biodiversity and ecosystem services that the majority of rural communities depend on for sustainable livelihoods. BIOPAMA aims to improve the long-term conservation, sustainable use of natural resources and ecosystem services in African, Caribbean and Pacific countries, in protected and conserved areas and surrounding communities.
The BIOPAMA Action Component provides funding opportunities to address protected and conserved areas, sustainable use of biodiversity, natural resources priorities for actions on the ground in African, Caribbean and the Pacific countries.
Priority driven, the objective of BIOPAMA Action Component is to improve biodiversity conservation in priority areas through funding tangible on the ground actions. From knowledge to action, the BIOPAMA Action Component is addressing key management and governance issues identified by diagnostic tools. Co-benefits for human well-being, livelihoods, as well as for climate change mitigation and adaptation actions, will be explicitly sought whenever possible.
Learn more about the current Calls for Proposals:
Additional Calls for Proposals will open soon, including a Small Technical Grant for Eastern and Southern Africa and a Small Technical Grant for the Caribbean. If you are interested in these, please visit the BIOPAMA Action Component site often, or subscribe to the BIOPAMA Funding Alert here.